130 related articles for article (PubMed ID: 33480092)
1. Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation, and oxidative stress in rats.
Luhach K; Kulkarni GT; Singh VP; Sharma B
Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):614-625. PubMed ID: 33480092
[TBL] [Abstract][Full Text] [Related]
2. Vinpocetine ameliorates developmental hyperserotonemia induced behavioral and biochemical changes: role of neuronal function, inflammation, and oxidative stress.
Luhach K; Kulkarni GT; Singh VP; Sharma B
Acta Neurobiol Exp (Wars); 2022; 82(1):35-51. PubMed ID: 35451422
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD.
Luhach K; Kulkarni GT; Singh VP; Sharma B
Eur J Pharmacol; 2021 Jan; 890():173663. PubMed ID: 33127361
[TBL] [Abstract][Full Text] [Related]
4. Papaverine ameliorates prenatal alcohol-induced experimental attention deficit hyperactivity disorder by regulating neuronal function, inflammation, and oxidative stress.
Sharma N; Dhiman N; Golani LK; Sharma B
Int J Dev Neurosci; 2021 Feb; 81(1):71-81. PubMed ID: 33175424
[TBL] [Abstract][Full Text] [Related]
5. Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress.
Luhach K; Kulkarni GT; Singh VP; Sharma B
Autism Res; 2021 Nov; 14(11):2270-2286. PubMed ID: 34415116
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
Luhach K; Kulkarni GT; Singh VP; Sharma B
J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
[TBL] [Abstract][Full Text] [Related]
7. A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress.
Mirza R; Sharma B
Chem Biol Interact; 2019 Sep; 311():108758. PubMed ID: 31348919
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice.
Hebb AL; Robertson HA; Denovan-Wright EM
Eur Neuropsychopharmacol; 2008 May; 18(5):339-63. PubMed ID: 17913473
[TBL] [Abstract][Full Text] [Related]
9. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
10. Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention deficit hyperactivity disorder.
Sharma N; Luhach K; Golani LK; Singh B; Sharma B
Alcohol; 2022 Dec; 105():25-34. PubMed ID: 35995260
[TBL] [Abstract][Full Text] [Related]
11. Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats.
Mirza R; Sharma B
Life Sci; 2018 Dec; 214():106-117. PubMed ID: 30366038
[TBL] [Abstract][Full Text] [Related]
12. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes.
McNamara IM; Borella AW; Bialowas LA; Whitaker-Azmitia PM
Brain Res; 2008 Jan; 1189():203-14. PubMed ID: 18062943
[TBL] [Abstract][Full Text] [Related]
13. Stereological Investigation of the Rat Ventral Thalamic Nuclei Following Developmental Hyperserotonemia.
Hough LH; Hill K; Staudt L; Grubb C; Green A
Neuroscience; 2019 Jul; 411():202-210. PubMed ID: 31170482
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
Mirza R; Sharma B
Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders.
Bhandari R; Kuhad A
Neurochem Int; 2017 Feb; 103():8-23. PubMed ID: 28025035
[TBL] [Abstract][Full Text] [Related]
17. Papaverine, a Phosphodiesterase 10A Inhibitor, Ameliorates Quinolinic Acid-Induced Synaptotoxicity in Human Cortical Neurons.
Bhat A; Tan V; Heng B; Chow S; Basappa S; Essa MM; Chidambaram SB; Guillemin GJ
Neurotox Res; 2021 Aug; 39(4):1238-1250. PubMed ID: 33914237
[TBL] [Abstract][Full Text] [Related]
18. Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism.
Wu H; Wang X; Gao J; Liang S; Hao Y; Sun C; Xia W; Cao Y; Wu L
Life Sci; 2017 Mar; 173():43-54. PubMed ID: 28161158
[TBL] [Abstract][Full Text] [Related]
19. The PDE10A inhibitor, papaverine, differentially activates ERK in male and female rat striatal slices.
Hsu YT; Liao G; Bi X; Oka T; Tamura S; Baudry M
Neuropharmacology; 2011 Dec; 61(8):1275-81. PubMed ID: 21816164
[TBL] [Abstract][Full Text] [Related]
20. Effects of developmental hyperserotonemia on the morphology of rat dentate nuclear neurons.
Hough LH; Segal S
Neuroscience; 2016 May; 322():178-94. PubMed ID: 26892293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
